Navigation Links
Recently FDA-Approved Full Neck Treatment for Sagging Skin Now Available at Maryland Laser Skin and Vein Institute
Date:12/28/2012

Baltimore, MD (PRWEB) December 28, 2012

Ultherapy non-surgical ultrasound treatments, which the physicians at the Maryland Laser, Skin and Vein Institute have been using for facial treatments, are now FDA-cleared for use to treat sagging skin on the neck and under the chin.

In a single treatment session, Ultherapy can tighten lax neck skin and improve firmness, all without any downtime. The Ulthera device uses sound waves targeted beneath the skin to gently heat, tighten and lift the skin, creating a younger, firmer look. And because Ulthera uses ultrasound, the surface skin is left undisturbed.

"We are excited to extend the range of Ultherapy treatments we offer to our patients for use on the neck,” says Dr. Weiss. “We’ve been having great results with Ulthera already on the face and already seeing improvements from application on the neck."

Based in Hunt Valley (Baltimore), MD, the MDLSV Institute not only treats thousands of patients per year, but is a leading clinical research facility investigating new skin treatments and devices for the purposes of FDA clearance and improving patient treatments and outcomes.

To schedule a consultation for treatment with Board Certified Dermatologists, please contact MDLSV (http://www.mdlsv.com)

Dr. Weiss, Director of the Maryland Laser Skin and Vein Institute, is one of America’s foremost dermatologists, and a past president of the American Society of Dermatologic Surgery. As an authority on dermatology, cosmetic dermatology and dermatologic surgery, laser medicine, and non-invasive body contouring, Dr. Weiss has been featured on national news programs such as 20/20 and The Today Show and is an author of multiple textbooks and textbook chapters on dermatology, lasers and cosmetic treatments such as botulinum toxin, fillers and spider veins.

Read the full story at http://www.prweb.com/releases/2012/12/prweb10273304.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Recently Published Economic Analysis Highlights the Financial Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) in the United States (US)
2. Stemedica Issued U.S. Patent For Stem Cell Treatment of Diabetic Retinopathy and Diabetic Optic Neuropathy
3. Mold Linked With Fatal Asthma and Allergy Attacks; Dr Mold Network Suggests Use of Molderizer and Safe Shield for Safer Mold Treatment
4. Milo Biotechnology Announces FDA Orphan Drug Designation for AAV1-FS344 for Treatment of Duchenne and Becker Muscular Dystrophy
5. CureLauncher is Described on LIVESTRONG Blog as Modern Platform That Gets People Involved in Advancing New Cancer Treatments
6. Sandy Mold Extends Its Health Risks to Hired Cleaners; My Cleaning Products Says Complete Mold Treatment Gear and Molderizer are Needed to Stop Mold and Its Risks
7. NKT Therapeutics Presents Data on Potential Antibody Treatment for Sickle Cell Disease
8. A Sewage Treatment Plant Goes Underground Using In-Pipe Technology Company, Inc. Bioaugmentation
9. Caris Sponsors CancerCare Connect Education Workshop on Molecular Profiling in the Treatment of Breast Cancer
10. Only 16% of Donations go to New Cancer Treatments in Some Charities. With cureLauncher, 91% of Contributions Go Directly to New Cures for Cancer.
11. University of College London Hospitals (UCLH) Selects GEO SCAN Medical as New Standard of Care for the Detection and Treatment of Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the ... the Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s ... how hardware projects are designed, built and brought to market. , The Design ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... On Wednesday, June 22, 2016, the NASDAQ Composite ... Jones Industrial Average edged 0.27% lower to finish at 17,780.83; ... has initiated coverage on the following equities: Infinity Pharmaceuticals Inc. ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ), ... more about these stocks by accessing their free trade alerts ...
Breaking Biology Technology:
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
Breaking Biology News(10 mins):